Prognostic value of cardiac magnetic resonance parameters and biomarkers following myocardial infarction; 10-year follow-up of the Eplerenone Remodelling in Myocardial Infarction without Heart Failure trial
- PMID: 34907636
- DOI: 10.1002/ejhf.2402
Prognostic value of cardiac magnetic resonance parameters and biomarkers following myocardial infarction; 10-year follow-up of the Eplerenone Remodelling in Myocardial Infarction without Heart Failure trial
References
-
- Hartley A, Marshall DC, Salciccioli JD, Sikkel MB, Maruthappu M, Shalhoub J. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009. Circulation. 2016;133:1916-26.
-
- Weir RA, Mark PB, Petrie CJ, Clements S, Steedman T, Ford I, et al. Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect? Am Heart J. 2009;157:1088-96.
-
- Eitel I, Pöss J, Jobs A, Eitel C, de Waha S, Barkhausen J, et al. Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2015;17:62.
-
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al.; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-77.
-
- Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Kofler M, Aschauer A, et al. Left ventricular global function index: relation with infarct characteristics and left ventricular ejection fraction after STEMI. Int J Cardiol. 2014;175:579-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
